Nucleai
Alon Groisman has several years of work experience in various roles. Starting in 2015, they worked as a Psychometric Instructor at High Q, providing instruction in this field. Alon then moved on to Refualaam (academylaam) in 2016, where they continued to work as a Psychometric Instructor until 2017. In 2018, they joined Nucleai as a Medical Data Project Lead. At Nucleai, they played a key role in their AI-powered precision oncology platform, collaborating with pharmaceutical companies and contributing to biomarker discovery projects. Also in 2018, they worked as a Histology Instructor at The Hebrew University of Jerusalem until 2019. Overall, Groisman has showcased their expertise in various fields and has accumulated valuable experience in the medical and educational sectors.
Alon Groisman pursued their education at The Hebrew University of Jerusalem from 2017 to 2023, where they obtained a Doctor of Medicine (MD) degree in the field of Medicine.
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.